CA-MIRO
28.4.2022 13:02:12 CEST | Business Wire | Press release
Miro , the online platform accelerating innovation through visual collaboration, today announced Miro Next , an all-virtual event revealing the next big thing for hybrid teams through the latest product and partner developments from the company. Miro Next will take place on May 18, 2022, at 8am PST / 5pm CEST and is purposefully designed to empower global teams to do more together.
Everyone is looking for new ways to succeed and thrive in today’s hybrid work environments. Some of the secrets to success include meetings that are more inclusive and interactive – blurring the lines between in-person and the virtual experience. Companies will need custom integrations between critical applications to help drive productivity and simplify the user experience, and more and more organizations will adopt agile practices that increase teamwork and speed innovation. Miro Next will explore these strategies, along with a host of updates on product features and enhancements, all designed to help organizations make hybrid work.
The event will kick off with a keynote presentation by Varun Parmar, Miro’s Chief Product Officer. Joined onstage with Miro partners and featured speakers, including Jeetu Patel of Cisco and Megan Cook of Atlassian, Parmar will show how Miro’s digital whiteboard is just the beginning of the future of visual collaboration.
“Miro Next will help us rediscover how to put people at the center of hybrid work, and in doing so, drive deeper engagement and collaboration among teams,” said Parmar. “I hope that teams all around the world will join us for this one-of-a-kind experience in just a few weeks.”
Miro Next will also feature a presentation led by Thor Mitchell, Miro’s Head of Product, Developer Platform, giving attendees an up-close-and-personal look at the next generation of Miro’s Developer Platform, and why it’s the perfect product to create an integrated collaboration experience that’s quick, easy, and seamless. The Miro Developer Platform was created three years ago to give any individual or enterprise the ability to build plugins and third-party integrations, and embed live Miro boards into other apps using Miro’s open API and SDKs. The Miro Developer Platform unlocks new, custom workflows to enhance the collaborative experience. At Miro Next, Airtable, ClickUp and others will join Mitchell to show how the Miro Developer Platform has unlocked new ways to harness visual collaboration using Miro and what they’re planning in the future.
In addition to learning about the future of visual collaboration from Miro product leaders and partners, Miro Next attendees will get exclusive access to breakout sessions to share ideas, ask questions, and connect with other Miro users who are seeking new ways to co-create with their teams, both synchronously and asynchronously. Miro Next breakout sessions include:
- The Road to Accessibility: A Collaborative Journey - Join Phil Strain, Miro Lead Product Manager for Accessibility and Design, and Sheri Byrne-Haber, VMWare Senior Staff Architect for Accessibility, to explore how an inclusive mindset can be a game-changer when it comes to company and end-user engagement.
- The Hybrid Workplace: Securing and Managing Collaboration In This New Way of Working - This thought leadership panel will include industry experts from Miro, Netskope, and Onna, sharing their top insights and practices for securing and managing hybrid workforces, while creating frictionless environments that help drive collaboration and creativity.
- Connected and Aligned: Your Hybrid Team in Miro - Join Miro’s team of customer education experts to learn how to use Miro features and skills to include all voices in collaborative work and create a one-stop Miro board for teams to gather information, share resources, and align expeditiously on what’s most important.
Miro Next will help all teams jump from “what now?” to “what’s next?” and explore their collaborative potential. Be among the first to preview new Miro features and get a sneak peek into the modern visual collaboration ecosystem:
- WHEN : May 18, 2022, 8 am PT/ 5 pm CET
- WHAT : One highlight-filled keynote session (60 minutes) and three, exclusive breakout sessions (60 minutes each)
- HOW : It’s virtual! RSVP for free at miro.com/next
About Miro
Miro is an online, visual collaboration platform designed to unlock creativity and accelerate innovation among teams of all kinds. The platform’s infinite canvas enables teams to lead engaging workshops and meetings, design products, brainstorm ideas, and more. Miro, co-headquartered in San Francisco and Amsterdam, serves more than 30M users worldwide, including 99% of the Fortune 100. Miro was founded in 2011 and currently has more than 1,400 employees in 10 hubs around the world. To learn more, please visit https://miro.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220428005447/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Kubota Vision Inc. Signs Supply and Licensing Agreement with Laboratoires KÔL for Stargardt Disease Treatment Candidate Under Compassionate Use4.5.2026 17:16:00 CEST | Press release
Kubota Vision Inc. (“Kubota Vision”), a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Minato-ku, Tokyo, Japan) announced signing of a Supply and Licensing Agreement with Laboratoires KÔL (Clermont-Ferrand, France) for the provision of a Stargardt disease (STGD1) treatment candidate under compassionate use authorization. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260414590785/en/ The purpose of this Agreement is for Kubota Vision and KÔL to collaborate on providing “Emixustat” for treatment of Stargardt Disease (STGD1) through compassionate use authorization in France. Kubota Vision will exclusively manufacture and supply Emixustat final products to KÔL and KÔL will have exclusive rights to distribute Emixustat in France under compassionate use access. Ryo Kubota, Chairman, President, and CEO of Kubota Pharmaceutical Holdings, stated, “We are extremely pleased to enter into this Agreement with Labor
Incentive Market Set to Surpass $80B by 2030s — IMA Launches Tools to Help the Industry Keep Pace4.5.2026 16:28:00 CEST | Press release
With combined business spend on loyalty, employee recognition, and channel incentives projected to exceed $80 billion by the 2030s, the incentive industry is entering a period of rapid scale and strategic pressure. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260422729016/en/ In response, the Incentive Marketing Association (IMA) launched a new suite of resources designed to help incentive professionals navigate an environment that’s becoming more specialized, fragmented, and central to business performance. “It’s not just more money coming in—it’s more complexity,” said Vince Chiofolo, President of the Incentive & Engagement Solution Providers (IESP). “Buyers are demanding programs that evolve fast, integrate deeply, and feel personal at scale. These new tools were built for that.” IMA’s Suite of Tools Includes: New Industry Report — Inside the Incentive Buyer’s Mind Drawn from insights of 50+ program owners, the report f
Tigo Energy Breaks Global Growth Benchmark; Boosts U.S. Energy Feature in Predict+4.5.2026 15:00:00 CEST | Press release
Advanced energy prediction platform adds real-time energy pricing for North American Independent System Operator (ISO) customers, accelerates meters-connected growth. Tigo Energy, Inc. (NASDAQ: TYGO) (“Tigo” or “Company”), a leading provider of intelligent solar and energy solutions, today announced that the Predict+ platform now offers integrated real-time spot market pricing for ISO customers in the United States. Predict+ provides utilities with deep insights into grid demand, renewable generation, and energy market dynamics, enhancing the precision, scalability, and robustness of energy forecasting to up to 97.5% accuracy through machine learning and artificial intelligence. For energy providers, Predict+ helps streamline operations, reduce volatility, and maximize performance. Predict+ empowers utility operators to adapt to real-world demand challenges when balancing renewable and baseload generation sources, particularly during extreme weather events and market disruptions. On th
Airship Announces 2026 Elevate Customer Experience Award Winners4.5.2026 15:00:00 CEST | Press release
Southwest Airlines, The Economist, and OneFootball among brands recognized at Elevate’26 Customer Experience Summit for setting the standard in mobile-first and AI-centered customer experiences Airship, the mobile-first customer experience company, today announced the winners of the 2026 Elevate Customer Experience Awards. Global brand leaders from The Economist, Southwest Airlines, and OneFootball were among those honored at the Elevate’26 Customer Experience Summit. The Elevate Awards spotlight global companies that have developed exceptional mobile-first customer experiences for their customers, created innovative campaigns, leveraged AI agents to reach new levels of productivity, and achieved real business results. "Evolving mobile-first consumer behaviors and unprecedented advancements in AI are driving a seismic shift that is reshaping how brands interact with their customers," said Brett Caine, CEO, Airship. "The 2026 Elevate Award winners aren’t just adapting, they’re leading t
Alnylam to Present New Analyses at Heart Failure 2026 Underscoring Consistent Clinical Profile of Vutrisiran in ATTR-CM4.5.2026 14:30:00 CEST | Press release
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced it will present new data analyses for vutrisiran in patients with the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) at Heart Failure 2026, a scientific congress of the European Society of Cardiology, taking place May 9-12, 2026, in Barcelona, Spain. ATTR-CM is a heterogeneous and rapidly progressive disease, and patients often present with complex clinical profiles. At Heart Failure 2026, Alnylam will present multiple new analyses from the Phase 3 HELIOS-B study of vutrisiran, which continue to support its use as a first-line treatment for patients with ATTR-CM, and further characterize its clinical profile across patients with a high disease burden, and in the context of concomitant therapies. Vutrisiran is the first and only transthyretin (TTR) silencer for ATTR-CM that delivers rapid knockdown of TTR at the source. Additional analyses being pr
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom